Thomas D. Nolin, PharmD, PhD

Thomas D. Nolin, PharmD, PhD

University of Pittsburgh

H-index: 50

North America-United States

About Thomas D. Nolin, PharmD, PhD

Thomas D. Nolin, PharmD, PhD, With an exceptional h-index of 50 and a recent h-index of 36 (since 2020), a distinguished researcher at University of Pittsburgh, specializes in the field of Clinical pharmacology, pharmacokinetics, nephrology, nephropharmacology, renal replacement therapy.

His recent articles reflect a diverse array of research interests and contributions to the field:

Impact of the 2021 CKD-EPI equation on anticancer pharmacotherapy in black and non-black cancer patients

Development and validation of an UPLC-MS/MS method for the simultaneous determination of fexofenadine and olmesartan in human serum: Application to in vivo pharmacokinetic studies

Development and validation of an ultra-high performance liquid chromatography-tandem mass spectrometry method to quantify antiretroviral drug concentrations in human plasma for …

Alpha-2-adrenergic agonists reduce resting energy expenditure in humans during external cooling

Electronic Health Record Population Health Management for Chronic Kidney Disease Care: A Cluster Randomized Clinical Trial

In Situ Formation of Fibronectin‐Enriched Protein Corona on Epigenetic Nanocarrier for Enhanced Synthetic Lethal Therapy

Metformin for sepsis-associated AKI: a protocol for the Randomized Clinical Trial of the Safety and FeasibiLity of Metformin as a Treatment for sepsis-associated AKI (LiMiT AKI)

Report of the 2023 AACP Council of Deans Taskforce on Pharmacy Research and Scholarship

Thomas D. Nolin, PharmD, PhD Information

University

Position

___

Citations(all)

7428

Citations(since 2020)

3908

Cited By

5099

hIndex(all)

50

hIndex(since 2020)

36

i10Index(all)

99

i10Index(since 2020)

87

Email

University Profile Page

University of Pittsburgh

Google Scholar

View Google Scholar Profile

Thomas D. Nolin, PharmD, PhD Skills & Research Interests

Clinical pharmacology

pharmacokinetics

nephrology

nephropharmacology

renal replacement therapy

Top articles of Thomas D. Nolin, PharmD, PhD

Title

Journal

Author(s)

Publication Date

Impact of the 2021 CKD-EPI equation on anticancer pharmacotherapy in black and non-black cancer patients

Cancer Letters

Morgan A Butrovich

Jiyue Qin

Xiaonan Xue

S Percy Ivy

Thomas D Nolin

...

2024/4/1

Development and validation of an UPLC-MS/MS method for the simultaneous determination of fexofenadine and olmesartan in human serum: Application to in vivo pharmacokinetic studies

Journal of Chromatography B

Elke Gasthuys

Judith van Ovost

Sofie Vande Casteele

Sarah Cosyns

Wim Ceelen

...

2024/2/1

Development and validation of an ultra-high performance liquid chromatography-tandem mass spectrometry method to quantify antiretroviral drug concentrations in human plasma for …

Journal of Chromatography B

Ignace C Roseboom

Bas Thijssen

Hilde Rosing

Fabiana Alves

Brima M Younis

...

2022/11/15

Alpha-2-adrenergic agonists reduce resting energy expenditure in humans during external cooling

Temperature

Clifton W Callaway

Katharyn L Flickinger

Alexandra Weissman

Francis X Guyette

Ryann DeMaio

...

2024/4/19

Electronic Health Record Population Health Management for Chronic Kidney Disease Care: A Cluster Randomized Clinical Trial

JAMA Internal Medicine

Manisha Jhamb

Melanie R Weltman

Susan M Devaraj

Linda-Marie Ustaris Lavenburg

Zhuoheng Han

...

2024/4/15

In Situ Formation of Fibronectin‐Enriched Protein Corona on Epigenetic Nanocarrier for Enhanced Synthetic Lethal Therapy

Advanced Science

Zhangyi Luo

Zhuoya Wan

Pengfei Ren

Bei Zhang

Yixian Huang

...

2024/3/14

Metformin for sepsis-associated AKI: a protocol for the Randomized Clinical Trial of the Safety and FeasibiLity of Metformin as a Treatment for sepsis-associated AKI (LiMiT AKI)

BMJ open

Ivan E Saraiva

Natsumi Hamahata

David T Huang

Sandra L Kane-Gill

Ryan M Rivosecchi

...

2024/4/1

Report of the 2023 AACP Council of Deans Taskforce on Pharmacy Research and Scholarship

Samuel M Poloyac

Kimberly K Daugherty

Melgardt M DeVilliers

Dorothy F Farrell

Ashim Malhotra

...

2024/1/6

Electronic health record based population health management to optimize care in CKD: Design of the Kidney Coordinated Health Management Partnership (K-CHAMP) trial

Contemporary Clinical Trials

Manisha Jhamb

Melanie R Weltman

Jonathan G Yabes

Sanjana Kamat

Susan M Devaraj

...

2023/8/1

Scribble scrambles parathyroid hormone receptor interactions to regulate phosphate and vitamin D homeostasis

Proceedings of the National Academy of Sciences

Bryce Z Stewart

Tatyana Mamonova

W Bruce Sneddon

Airah Javorsky

Yanmei Yang

...

2023/6/6

Improved antitumor activity against prostate cancer via synergistic targeting of Myc and GFAT-1

Theranostics

Yue Zhang

Jiang Li

Yixian Huang

Yuang Chen

Zhangyi Luo

...

2023

Fexofenadine Plasma Concentrations to Estimate Systemic Exposure in Healthy Adults Using a Limited Sampling Strategy with a Population Pharmacokinetic Approach

Therapeutic Drug Monitoring

Joseph Piscitelli

Mina Nikanjam

Edmund V Capparelli

Chelsea L Blaquera

Scott R Penzak

...

2023/8/1

Limitations of fexofenadine limited sampling strategy using plasma concentrations and partial area under the concentration-time curve to estimate transporter activity in …

International Journal of Clinical Pharmacology and Therapeutics

Marlon Liyanage

Chelsea L Blaquera

Joseph Piscitelli

Scott R Penzak

Thomas D Nolin

...

2023/6

Discordance in GFR estimating equations and dosing guidance by body mass index and age

American Journal of Kidney Diseases

Beini Lyu

Yunwen Xu

Lesley A Inker

Alexander R Chang

Thomas D Nolin

...

2023/10/1

Transdermal Detection of MB-102 and Correlation to Meropenem Pharmacokinetics During Continuous Renal Replacement Therapy: In Vivo Results

Asaio Journal

Richard B Dorshow

James R Johnson

Jeng-Jong Shieh

I Rochelle Riley

Thomas E Rogers

...

2023/7/1

Overcoming pancreatic cancer immune resistance by codelivery of CCR2 antagonist using a STING-activating gemcitabine-based nanocarrier

Materials Today

Zhuoya Wan

Haozhe Huang

Raymond E West III

Min Zhang

Bei Zhang

...

2023/1/1

258. Clinical Rel Mutations in Staphylococcus aureus Primes Pathogen Expansion Under Nutrient Stress

Open Forum Infectious Diseases

Edwin Chen

Marla G Shaffer

Robert E Bilodeau

Raymond E West III

Patrick J Oberly

...

2023/12

Clinical rel mutations in Staphylococcus aureus prime pathogen expansion under nutrient stress

Msphere

Edwin Chen

Marla G Shaffer

Robert E Bilodeau

Raymond E West III

Patrick J Oberly

...

2023/9/24

Inclusion of participants with CKD and other kidney-related considerations during clinical drug development: landscape analysis of anticancer agents approved from 2015 to 2019

Clinical Journal of the American Society of Nephrology

Morgan A Butrovich

Allison C Reaves

Jamie Heyward

Thomas J Moore

G Caleb Alexander

...

2023/4/1

Pharmacokinetics in patients requiring renal replacement therapy

Arthur J Atkinson Jr

Thomas D Nolin

John M Allen

2022/1/1

See List of Professors in Thomas D. Nolin, PharmD, PhD University(University of Pittsburgh)

Co-Authors

H-index: 106
Jonathan Himmelfarb

Jonathan Himmelfarb

University of Washington

H-index: 35
Sophie Gosselin MD

Sophie Gosselin MD

McGill University

H-index: 10
Alexander J. Prokopienko

Alexander J. Prokopienko

University of Pittsburgh

academic-engine